COVID-19 Ups Complication Risks During Childbirth

WEDNESDAY, Jan. 20, 2021 (HealthDay News) — Women who have COVID-19 during childbirth are more likely to face complications than moms-to-be without the coronavirus, researchers say.

Fortunately, the absolute risk for complications for any one woman is very low (less than 1%). But the relative risks for problems — such as clotting and early labor — are significant, the new study found.

Still, “the findings here, truly, are that among women who are hospitalized for childbirth and who were diagnosed with COVID, adverse events are incredibly low. That should provide a lot of reassurance to women who are hoping to become pregnant during this period, or who are pregnant,” said study co-author Dr. Karola Jering, from the cardiovascular medicine division at Brigham and Women’s Hospital in Boston.

Over eight months in 2020, she and her colleagues collected data on more than 400,000 mothers-to-be, nearly 6,400 of whom were infected with COVID-19.

Among the COVID-19 patients, the researchers found the relative risk of developing any type of blood clot was nearly five times higher than for those without the virus, and nearly four times higher for venous thromboembolism, clots in the veins.

These women were also far more likely to need intensive care or a ventilator, the researchers found.

Those who had the virus were:

  • 7% more likely to need a C-section.
  • 19% more likely to have preterm labor.
  • 17% more likely to have a preterm delivery.
  • 21% more likely to have preeclampsia.

There’s little a pregnant woman can do to reduce these risks beyond not being infected, Jering said.

“The problem, of course, is that right now we mostly have supportive care for patients who have COVID, in general. And of the things that have been tested for treatment of patients with COVID, most of them have not been tested in pregnant women,” said co-author Dr. Scott Solomon, also from Brigham and Women’s.

But Jering said pregnant women are given the other drugs often given to COVID-19 patients, including blood thinners to prevent clots.

In sum, the study findings were positive, Jering stressed. Among the pregnant women with COVID-19 who gave birth, 99% were discharged home, 3% needed intensive care and 1% needed mechanical ventilation. Less than 1% died in the hospital.

Source link


For Biden, 100 Million Vaccinations in 100 Days Not Easy

By Victoria Knight

Wednesday, January 20, 2021 (Kaiser News) — This story also ran on PolitiFact. It can be republished for free.

It’s in the nature of presidential candidates and new presidents to promise big things. Just months after his 1961 inauguration, President John F. Kennedy vowed to send a man to the moon by the end of the decade. That pledge was kept, but many others haven’t been, such as candidate Bill Clinton’s promise to provide universal health care and presidential hopeful George H.W. Bush’s guarantee of no new taxes.

Now, during a once-in-a-century pandemic, incoming President Joe Biden has promised to provide 100 million covid-19 vaccinations in his first 100 days in office.

“This team will help get … at least 100 million covid vaccine shots into the arms of the American people in the first 100 days,” Biden said during a Dec. 8 news conference introducing key members of his health team.

When first asked about his pledge, the Biden team said the president-elect meant 50 million people would get their two-dose regimen. The incoming administration has since updated this plan, saying it will release vaccine doses as soon as they’re available instead of holding back some of that supply for second doses.

Either way, Biden may run into difficulty meeting that 100 million mark.

“I think it’s an attainable goal. I think it’s going to be extremely challenging,” said Claire Hannan, executive director of the Association of Immunization Managers.

While a pace of 1 million doses a day is “somewhat of an increase over what we’re already doing,” a much higher rate of vaccinations will be necessary to stem the pandemic, said Larry Levitt, executive vice president for health policy at KFF. (KHN is an editorially independent program of KFF.) “The Biden administration has plans to rationalize vaccine distribution, but increasing the supply quickly” could be a difficult task.

Under the Trump administration, vaccine deployment has been much slower than Biden’s plan. The rollout began more than a month ago, on Dec. 14. Since then, 12 million shots have been given and 31 million doses have been shipped out, according to the Centers for Disease Control and Prevention’s vaccine tracker.


This sluggishness has been attributed to a lack of communication between the federal government and state and local health departments, not enough funding for large-scale vaccination efforts, and confusing federal guidance on distribution of the vaccines.

The same problems could plague the Biden administration, said experts.

States still aren’t sure how much vaccine they’ll get and whether there will be a sufficient supply, said Dr. Marcus Plescia, chief medical officer for the Association of State and Territorial Health Officials, which represents state public health agencies.

“We have been given little information about the amount of vaccine the states will receive in the near future and are of the impression that there may not be 1 million doses available per day in the first 100 days of the Biden administration,” said Plescia. “Or at least not in the early stages of the 100 days.”

Another challenge has been a lack of funding. Public health departments have had to start vaccination campaigns while also operating testing centers and conducting contact tracing efforts with budgets that have been critically underfunded for years.

“States have to pay for creating the systems, identifying the personnel, training, staffing, tracking people, information campaigns — all the things that go into getting a shot in someone’s arm,” said Jennifer Kates, director of global health & HIV policy at KFF. “They’re having to create an unprecedented mass vaccination program on a shaky foundation.”

The latest covid stimulus bill, signed into law in December, allocates almost $9 billion in funding to the CDC for vaccination efforts. About $4.5 billion is supposed to go to states, territories and tribal organizations, and $3 billion of that is slated to arrive soon.

But it’s not clear that level of funding can sustain mass vaccination campaigns as more groups become eligible for the vaccine.

Biden released a $1.9 trillion plan last week to address covid and the struggling economy. It includes $160 billion to create national vaccination and testing programs, but also earmarks funds for $1,400 stimulus payments to individuals, state and local government aid, extension of unemployment insurance, and financial assistance for schools to reopen safely.


Though it took Congress almost eight months to pass the last covid relief bill after Republican objections to the cost, Biden seems optimistic he’ll get some Republicans on board for his plan. But it’s not yet clear that will work.

There’s also the question of whether outgoing President Donald Trump’s impeachment trial will get in the way of Biden’s legislative priorities.

In addition, states have complained about a lack of guidance and confusing instructions on which groups should be given priority status for vaccination, an issue the Biden administration will need to address.

On Dec. 3, the CDC recommended health care personnel, residents of long-term care facilities, those 75 and older, and front-line essential workers should be immunized first. But on Jan. 12, the CDC shifted course and recommended that everyone over age 65 should be immunized. In a speech Biden gave last week detailing his vaccination plan, he said he would stick to the CDC’s recommendation to prioritize those over 65.

Outgoing Health and Human Services Secretary Alex Azar also said Jan. 12 that states that moved their vaccine supply fastest would be prioritized in getting more shipments. It’s not known yet whether the Biden administration’s CDC will stick to this guidance. Critics have said it could make vaccine distribution less equitable.

In general, taking over with a strong vision and clear communication will be key to ramping up vaccine distribution, said Hannan.

“Everyone needs to understand what the goal is and how it’s going to work,” she said.

A challenge for Biden will be tamping expectations that the vaccine is all that is needed to end the pandemic. Across the country, covid cases are higher than ever, and in many locations officials cannot control the spread.

Public health experts said Biden must amp up efforts to increase testing across the country, as he has suggested he will do by promising to establish a national pandemic testing board.

With so much focus on vaccine distribution, it’s important that this part of the equation not be lost. Right now, “it’s completely all over the map,” said KFF’s Kates, adding that the federal government will need a “good sense” of who is and is not being tested in different areas in order to “fix” public health capacity.

WebMD News from Kaiser Health News

©2013-2020 Henry J. Kaiser Family Foundation. All rights reserved.

Source link


Nearly 45,000 Floridians Overdue for 2nd Second Vaccine

Jan. 20, 2021 — More than 1 million people in Florida have received a COVID-19 vaccine, but 44,500 are overdue for their second dose, according to the Florida Department of Health.

The recommended timeframe to receive a second dose is 21 days for the Pfizer-BioNTech vaccine and 28 days for the Moderna vaccine. Those who don’t receive a second dose aren’t considered fully immunized against the coronavirus.

Health care workers expected to see some issues around second doses, according to CBS 12 News in West Palm Beach. Some vaccine recipients are concerned about experiencing more serious side effects after the second dose and are afraid to get it. However, doctors and nurses are urging patients to get their second shot to make sure they’ve reached the 95% efficacy level for the two-shot regimen, even if they’re late.

“I am a great example, I got my second dose today,” Kitonga Kiminyo, MD, an infectious disease specialist at T. Leroy Jefferson Medical Society, told the news station. “Trust me, nothing worse is going to happen after you get the second shot.”

Local health departments are also trying to stay on top of scheduling and vaccine supplies to ensure that people take their second dose on time. So far, more than 100,000 Floridians have taken both doses of a COVID-19 vaccine, and about 920,000 are on track to receive their second dose, the Florida Department of Health reported.

“Without knowing the ‘why’ here, it is challenging to know whether it should be concerning,” Jason Salemi, an epidemiology professor at the University of South Florida, told the South Florida Sun Sentinel.

“Right now, I’m not concerned,” he said. “But if that number continues to grow … or the reasons for missing the second dose are concerning (such as no doses available, people unable to make it to their appointments in a timely manner), then I’d be brainstorming effective solutions.”

WebMD Health News


Florida Department of Health, “COVID-19: vaccine summary.”
CBS 12 News, “Supply issues or side effects? 45,000 Floridians overdue for second COVID-19 vaccine dose.”
South Florida Sun Sentinel, “Vaccine in Florida: More than 40,000 people overdue for second dose.”

© 2021 WebMD, LLC. All rights reserved.

Source link

Headline USA

Raúl González tested positive for COVID-19 | The State

Raúl González during a match with the white club.

Dani Pozo / AFP / Getty Images

He Real Madrid confirmed what had been speculated for a few hours: Raul Gonzalez the former player of the team and now DT of Real Madrid Castilla tested positive for COVID-19.

The news was confirmed by the club to EFE, an agency that ensures that the former player is already isolated At home since Monday afternoon, when he learned of the positive.

Due to this result in the test, Raúl González he will not be able to sit on the Castilla bench for next Sunday’s game when the team faces the Getafe B.

The Madrid affiliate has not competed for more than a month. His last official match was the victory on December 13 against Atlético de Madrid B, although later he played a friendly against Móstoles on Sunday, January 3.



Nasal Spray Vaccine for COVID-19 in Early Trials

TUESDAY, Jan. 19, 2021 (HealthDay News) — A spritz instead of a shot to ward off COVID-19? Researchers report that a nasal spray vaccine against the new coronavirus shows promise in animal testing.

Rodents that were given two doses of the vaccine had antibody and T-cell responses that were strong enough to suppress SARS-CoV-2, the coronavirus that causes COVID-19.

The vaccine also reduced lung damage, inflammation and disease severity in the rodents, according to scientists from Lancaster University in England and Texas Biomedical Research Institute in San Antonio.

“We found that administering this vaccine through a nasal spray completely protected the animals from shedding the virus which causes transmission of the virus. This means the immunization of the upper respiratory tract through a nasal spray can prevent individuals from spreading the virus and developing infections elsewhere in the body,” said study author Muhammad Munir, a Lancaster University virologist.

“Though the vaccine showed promising safety and efficacy in this animal model, human trials are still required to determine its applicability and to obtain regulatory approvals,” Munir added in a university news release.

The nasal spray vaccine is based on a common poultry virus called the Newcastle Disease Virus (NDV), which can replicate in humans but is harmless. The research team engineered NDV to produce the spike proteins of the SARS-CoV-2 virus to prime the body’s immune system to attack the coronavirus.

Their findings were published recently on BioRxiv, a preprint server for research that hasn’t yet been peer-reviewed.

There are a number of advantages to a nasal spray vaccine, including it being noninvasive, triggering local immunity, and being an alternative for people who are afraid of needles or have blood clotting disorders, according to the researchers.

They noted that there’s already a nasal spray vaccine for seasonal flu, so this type of vaccination has been proven to be effective.

A nasal spray vaccine for COVID-19 could provide a low-cost alternative for the developing world, because it could be produced using existing worldwide infrastructure for seasonal flu virus vaccines, the researchers suggested.

“The scalability and economical production make this vaccine candidate suitable for low- and middle-income countries,” said study author Mohammed Rohaim, also from Lancaster University.

More information

The U.S. Centers for Disease Control and Prevention has more on COVID-19 vaccines.

SOURCE: Lancaster University, news release, Jan. 13, 2021

Source link


Do You Socially Distance? Your Income Might Matter

By Cara Murez

HealthDay Reporter

TUESDAY, Jan. 19, 2021 (HealthDay News) — Do you you keep 6 feet apart from others to help stop coronavirus spread? New research shows that the wealthier you were at the start of the pandemic, the more likely it is you’ll maintain social distance.

The new study looked at social distancing and mask wearing, and determined a link between those behaviors and income.

“We need to understand these differences because we can wring our hands, and we can blame and shame, but in a way it doesn’t matter,” said study author Nick Papageorge, the Broadus Mitchell Associate Professor of Economics at Johns Hopkins University in Baltimore.

“Policymakers just need to recognize who is going to socially distance, for how long, why and under what circumstances to give us accurate predictions of how the disease will spread and help us establish policies that will be useful,” he said in a Hopkins news release.

The research was part of a six-country survey. In the United States, 1,000 people from Texas, Florida, California and New York were asked questions last April about demographic information and their behavior as COVID-19 cases were spiking.

People with the highest incomes made the most changes. They were 32% more likely to increase social distancing, 30% more likely to increase hand-washing and mask wearing and 13% more likely to change behaviors.

The ability to work from home and having access to outdoor space made a significant difference.

People with higher incomes were more likely to be able to work from home, which made them 24% more likely to keep social distance. Lower-income people experienced increased chances of losing their job because of the pandemic, and they also had limited access to remote work, the study found.

“The whole messaging of this pandemic is you’re stuck at home teleworking, that must be really tough so here are some recipes for sourdough starter, and here’s what you should catch up on Netflix,” Papageorge said. “But what about the people who aren’t teleworking? What are they going to do?”


People with access to the outdoors at home were 20% more likely to maintain social distance.

“It’s not shocking that if you don’t live in a comfortable house you’re going to be leaving your house more often,” Papageorge said. “But the point we want to push is that if I’m a policymaker maybe I really need to think about opening city parks in a dense neighborhood during a pandemic. Maybe that’s something that’s worth the risk. This is why we want to understand these details — they can eventually suggest policies.”

The study also found that women were 23% more likely than men to social distance. There was not a meaningful difference in social distancing behavior because of preexisting health conditions.

The research was published Jan. 14 in the Journal of Population Economics.

More information

The U.S. Centers for Disease Control and Prevention has more information on protecting yourself and others from COVID-19.

SOURCE: Johns Hopkins University, news release, Jan. 14, 2021

WebMD News from HealthDay

Copyright © 2013-2020 HealthDay. All rights reserved.

Source link


Black Americans Getting Vaccinated at Lower Rates

By Hannah Recht and Lauren Weber

Sunday, January 17, 2021 (Kaiser News) — Black Americans are receiving covid vaccinations at dramatically lower rates than white Americans in the first weeks of the chaotic rollout, according to a new KHN analysis.

About 3% of Americans have received at least one dose of a coronavirus vaccine so far. But in 16 states that have released data by race, white residents are being vaccinated at significantly higher rates than Black residents, according to the analysis — in many cases two to three times higher.

In the most dramatic case, 1.2% of white Pennsylvanians had been vaccinated as of Jan. 14, compared with 0.3% of Black Pennsylvanians.

The vast majority of the initial round of vaccines has gone to health care workers and staffers on the front lines of the pandemic — a workforce that’s typically racially diverse made up of physicians, hospital cafeteria workers, nurses and janitorial staffers.

If the rollout were reaching people of all races equally, the shares of people vaccinated whose race is known should loosely align with the demographics of health care workers. But in every state, Black Americans were significantly underrepresented among people vaccinated so far.

Access issues and mistrust rooted in structural racism appear to be the major factors leaving Black health care workers behind in the quest to vaccinate the nation. The unbalanced uptake among what might seem like a relatively easy-to-vaccinate workforce doesn’t bode well for the rest of the country’s dispersed population.

Black, Hispanic and Native Americans are dying from covid at nearly three times the rate of white Americans, according to a Centers for Disease Control and Prevention analysis. And non-Hispanic Black and Asian health care workers are more likely to contract covid and to die from it than white workers. (Hispanics can be of any race.)

“My concern now is if we don’t vaccinate the population that’s highest-risk, we’re going to see even more disproportional deaths in Black and brown communities,” said Dr. Fola May, a UCLA physician and health equity researcher. “It breaks my heart.”


Dr. Taison Bell, a University of Virginia Health System physician who serves on its vaccination distribution committee, stressed that the hesitancy among some Blacks about getting vaccinated is not monolithic. Nurses he spoke with were concerned it could damage their fertility, while a Black co-worker asked him about the safety of the Moderna vaccine since it was the company’s first such product on the market. Some floated conspiracy theories, while other Black co-workers just wanted to talk to someone they trust like Bell, who is also Black.

But access issues persist, even in hospital systems. Bell was horrified to discover that members of environmental services — the janitorial staff — did not have access to hospital email. The vaccine registration information sent out to the hospital staff was not reaching them.

“That’s what structural racism looks like,” said Dr. Georges Benjamin, executive director of the American Public Health Association. “Those groups were seen and not heard — nobody thought about it.”

UVA Health spokesperson Eric Swenson said some of the janitorial crew were among the first to get vaccines and officials took additional steps to reach those not typically on email. He said more than 50% of the environmental services team has been vaccinated so far.

A Failure of Federal Response

As the public health commissioner of Columbus, Ohio, and a Black physician, Dr. Mysheika Roberts has a test for any new doctor she sees for care: She makes a point of not telling them she’s a physician. Then she sees if she’s talked down to or treated with dignity.

That’s the level of mistrust she says public health officials must overcome to vaccinate Black Americans — one that’s rooted in generations of mistreatment and the legacy of the infamous Tuskegee syphilis study and Henrietta Lacks’ experience.

A high-profile Black religious group, the Nation of Islam, for example, is urging its members via its website not to get vaccinated because of what Minister Louis Farrakhan calls the “treacherous history of experimentation.” The group, classified as a hate group by the Southern Poverty Law Center, is well known for spreading conspiracy theories.


Public health messaging has been slow to stop the spread of misinformation about the vaccine on social media. The choice of name for the vaccine development, “Operation Warp Speed,” didn’t help; it left many feeling this was all done too fast.

Benjamin noted that while the nonprofit Ad Council has raised over $37 million for a marketing blitz to encourage Americans to get vaccinated, a government ad campaign from the Health and Human Services Department never materialized after being decried as too political during an election year.

“We were late to start the planning process,” Benjamin said. “We should have started this in April and May.”

And experts are clear: It shouldn’t merely be ads of famous athletes or celebrities getting the shots.

“We have to dig deep, go the old-fashioned way with flyers, with neighbors talking to neighbors, with pastors talking to their church members,” Roberts said.

Speed vs. Equity

Mississippi state Health Officer Dr. Thomas Dobbs said that the shift announced Tuesday by the Trump administration to reward states that distribute vaccines quickly with more shots makes the rollout a “Darwinian process.”

Dobbs worries Black populations who may need more time for outreach will be left behind. Only 18% of those vaccinated in Mississippi so far are Black, in a state that’s 38% Black.

It might be faster to administer 100 vaccinations in a drive-thru location than in a rural clinic, but that doesn’t ensure equitable access, Dobbs said.

“Those with time, computer systems and transportation are going to get vaccines more than other folks — that’s just the reality of it,” Dobbs said.

In Washington, D.C, a digital divide is already evident, said Dr. Jessica Boyd, the chief medical officer of Unity Health Care, which runs several community health centers. After the city opened vaccine appointments to those 65 and older, slots were gone in a day. And Boyd’s staffers couldn’t get eligible patients into the system that fast. Most of those patients don’t have easy access to the internet or need technical assistance.


“If we’re going to solve the issues of inequity, we need to think differently,” Boyd said.

Dr. Marcus Plescia, chief medical officer at the Association of State and Territorial Health Officials, said the limited supply of vaccine must also be considered.

“We are missing the boat on equity,” he said. “If we don’t step back and address that, it’s going to get worse.”

While Plescia is heartened by President-elect Joe Biden’s vow to administer 100 million doses in 100 days, he worries the Biden administration could fall into the same trap.

And the lack of public data makes it difficult to spot such racial inequities in real time. Fifteen states provided race data publicly, Missouri did so upon request, and eight other states declined or did not respond. Several do not report vaccination numbers separately for Native Americans and other groups, and some are missing race data for many of those vaccinated. The CDC plans to add race and ethnicity data to its public dashboard, but CDC spokesperson Kristen Nordlund said it could not give a timeline for when.

Historical Hesitation

One-third of Black adults in the U.S. said they don’t plan to get vaccinated, citing the newness of the vaccine and fears about safety as the top deterrents, according to a December poll from KFF. (KHN is an editorially independent program of KFF.) Half of them said they were concerned about getting covid from the vaccine itself, which is not possible.

Experts say this kind of misinformation is a growing problem. Inaccurate conspiracy theories that the vaccines contain government tracking chips have gained ground on social media.

Just over half of Black Americans who plan to get the vaccine said they’d wait to see how well it’s working in others before getting it themselves, compared with 36% of white Americans. That hesitation can even be found in the health care workforce.

“We shouldn’t make the assumption that just because someone works in health care that they somehow will have better information or better understanding,” Bell said.


In Colorado, Black workers at Centura Health were 44% less likely to get the vaccine than their white counterparts. Latino workers were 22% less likely. The hospital system of more than 21,000 workers is developing messaging campaigns to reduce the gap.

“To reach the people we really want to reach, we have to do things in a different way, we can’t just offer the vaccine,” said Dr. Ozzie Grenardo, a senior vice president and chief diversity and inclusion officer at Centura. “We have to go deeper and provide more depth to the resources and who is delivering the message.”

That takes time and personal connections. It takes people of all ethnicities within those communities, like Willy Nuyens.

Nuyens, who identifies as Hispanic, has worked for Kaiser Permanente Los Angeles Medical Center for 33 years. Working on the environmental services staff, he’s now cleaning covid patients’ rooms. (KHN is not affiliated with Kaiser Permanente.)

In Los Angeles County, 92% of health care workers and first responders who have died of covid were nonwhite. Nuyens has seen too many of his co-workers lose family to the disease. He jumped at the chance to get the vaccine but was surprised to hear only 20% of his 315-person department was doing the same.

So he went to work persuading his co-workers, reassuring them that the vaccine would protect them and their families, not kill them.

“I take two employees, encourage them and ask them to encourage another two each,” he said.

So far, uptake in his department has more than doubled to 45%. He hopes it will be over 70% soon.

Kaiser Health News (KHN) is a national health policy news service. It is an editorially independent program of the Henry J. Kaiser Family Foundation which is not affiliated with Kaiser Permanente.

WebMD News from Kaiser Health News

©2013-2020 Henry J. Kaiser Family Foundation. All rights reserved.

Source link


Experts Call for Better Masks As Pandemic Rolls On

Abraar Karan, MD, Brigham and Women’s Hospital and Harvard Medical School, Boston.

Tom Frieden, MD,

Monica Gandhi, MD, University of California, San Francisco.

Alice Sato, MD, PhD, Children’s Hospital & Medical Center, Omaha, NE.

Cell: “Uniting Infectious Disease and Physical Science Principles on the Importance of Face Masks for COVID-19.”

 JAMA Internal Medicine: “Evaluation of Cloth Masks and Modified Procedure Masks as Personal Protective Equipment for the Public During the COVID-19 Pandemic.”

Proceedings of the National Academy of Sciences: “Face masks considerably reduce COVID-19 cases in Germany.”

The Local: “Austrian government to distribute free FFP2 masks to over 65s ‘by mid-January.’” “Your Guide to Masks,” “Trends in County-Level COVID-19 Incidence in Counties With and Without a Mask Mandate — Kansas, June 1-August 23, 2020,”

“Trends in COVID-19 Incidence After Implementation of Mitigation Measures — Arizona, January 22-August 7, 2020,” “Emergence of SARS-CoV-2 B.1.1.7 Lineage — United States, December 29, 2020-January 12, 2021.”

The Atlantic: “Why Aren’t We Wearing Better Masks?”

The Lancet: “Mask-wearing linked to reduced COVID-19 transmission, US modelling study suggests.”

Source link

Headlines UK London

One in ten UK residents has antibodies to coronavirus

Highest rates recorded in Yorkshire and the Humber

One in ten people in the UK has antibodies to coronavirus, the BBC reports, citing data from the UK’s National Statistical Office (ONS). Virus and antibody testing was conducted in December 2020. It was attended by both people who had recovered and those who did not have visible symptoms of the disease.

In England, this figure is slightly higher – there are antibodies in every eighth (this is about 12% of the total population). In Wales, one in ten (10%), in Scotland, one in eleven (9%), in Northern Ireland, one in thirteen (8%).

The highest rates by region were recorded in Yorkshire and the Humber, where 17% of the population have antibodies. London is in second place (16%).

In October 2020, 2-7% of the UK population had antibodies. “The study shows that the infection is much more common in the UK than previously thought.”Says Professor Lawrence Young, virologist at Warwick School of Medicine.

The presence of antibodies in the blood of a person indicates that he has suffered viral pneumonia in one form or another and has developed protection against recurrence of the disease. Public Health England claims that on average, immune defenses last at least five months.

Headline USA

Gabriel Coronel won the battle against COVID-19 | The State

Gabriel Coronel.

Gabriel Coronel / Courtesy

Gabriel Coronel confirms that he tested negative for COVID-19 that was done this weekend.

After nearly 20 days of battling, the actor broke the happy news like this:

“Negative to COVID-19 … I can only thank God, my saints, life and you for all your messages ✨ .. !! Take care that this is not recommended to anyone .. ❌🦠🙏🏻 .. !! I love you ❤️ ”The singer and actor wrote on his Instagram account where he showed the result and was photographed looking at the sky as a symbol of gratitude.

A few days ago we told you that Gabriel was one of those who was saved from contagion in ‘Your face is familiar to me’ But, unfortunately, 2021 began with the positive COVID-19 test.

Locked up in his Miami apartment, the beloved Venezuelan actor and singer spent more than two weeks battling the virus that has not treated him very well.

“I’ve had a pretty bad time. A lot of pain in the body, in the head. A rare disease that not only plays with your physical health, but also with your mental health “Coronel assured a few days before knowing the negative result.

Gabriel was participating a few months ago in ‘Tu Cara Me Suena’, where Llanes, Melina León, Sandra Echeverría, Francisca Lachapel and Chantal Andere were infected with coronavirus. He had been saved, Pablo Montero and The Dasa.

Happy with having the virus out of his system, he tells us that he still feels short of breath and assures that he does not wish anyone what he has lived through all these days, so he asks the public to take the issue seriously and take care.